Trial Profile

Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 23 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BPI-442096 (Primary)
Indications Colorectal cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
Focus Adverse reactions; First in man
Sponsors Betta Pharmaceuticals Co Ltd

Most Recent Events

15 Jun 2022 Planned initiation date changed from 23 May 2022 to 1 Jun 2022.
17 May 2022 Planned initiation date changed from 1 May 2022 to 23 May 2022.
13 May 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com